IP48-09: From Routine to Restricted: Impact of the FDA Black Box Warning on Fluoroquinolones on the Treatment of Simple Cystitis in Women

IP48-09: From Routine to Restricted: Impact of the FDA Black Box Warning on Fluoroquinolones on the Treatment of Simple Cystitis in Women

Saturday, May 16, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
147B
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!